WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Close Notification

Your cart does not contain any items

Drug Development for Rare Diseases by Bo Yang at Abbey's Bookshop,
Drug Development for Rare Diseases
— —
Bo Yang Yang Song

Drug Development for Rare Diseases

Bo Yang,  Yang Song,  Yijie Zhou

$263

Hardback

Not in-store but you can order this
How long will it take?
English
Chapman & Hall/CRC
13 February 2023
Clinical trials; Probability & statistics; Biology, life sciences; Pharmaceutical technology
Series: Chapman & Hall/CRC Biostatistics Series
A disease is defined as rare if the prevalence is fewer than 200,000 in the United States. It is estimated that there are more than 7,000 rare diseases, which collectively affect 30 million Americans or 10% of the US population. This diverse and complex disease area poses challenges for patients, caregivers, regulators, drug developers, and other stakeholders. This book is proposed

to give an overview of the common issues facing rare disease drug developers, summarize challenges specific to clinical development in small populations, discuss drug development strategies in the evolving regulatory environment, explain generation and utilization of different data and evidence

inside and beyond clinical trials, and use recent examples to demonstrate these challenges and the development strategies that respond to the challenges.

Key Features:

• Rare disease.

• Drug development.

• Innovative clinical trial design.

• Regulatory approval.

• Real-world evidence.
Edited by:   , ,
Imprint:   Chapman & Hall/CRC
Country of Publication:   United Kingdom
Dimensions:   Height: 234mm,  Width: 156mm, 
Weight:   589g
ISBN:   9780367518349
ISBN 10:   0367518341
Series:   Chapman & Hall/CRC Biostatistics Series
Pages:   222
Publication Date:  
Audience:   General/trade ,  ELT Advanced
Format:   Hardback
Publisher's Status:   Active

Bo Yang is the Vice President, Biometrics and Real World Evidence at Vertex Pharmaceuticals, USA. Yang Song is the Executive Director, Biostatistics Group Head of Pipeline Development at Vertex Pharmaceuticals, USA. Yijie Zhou is the Executive Director, Real World Statistics and Analytics at Vertex Pharmaceuticals, USA.

See Also

Drug Development for Rare Diseases

Applied Reliability

Paul A. Tobias

Paperback

$94.99 

Not in-store but you can order this

ADD +
Drug Development for Rare Diseases

Bayesian Decision Analysis

Principles and Practice

Jim Q. Smith (University of Warwick)...

Hardback

$103.95 

In Stock 😊

ADD +
Drug Development for Rare Diseases

Generalized Additive Models

An Introduction with R, Second Edition...

Simon N. Wood

Hardback

$162 

Not in-store but you can order this

ADD +
Drug Development for Rare Diseases

The Art of Statistics

Learning from Data

David Spiegelhalter

Paperback

$24.99 

In Stock 😊

ADD +
Drug Development for Rare Diseases

Introduction to Credit Risk Modeling...

Christian Bluhm

Paperback

$96.99 

Not in-store but you can order this

ADD +
Drug Development for Rare Diseases

Multiple Factor Analysis by Example...

Jérôme Pagès

Paperback

$94.99 

Not in-store but you can order this

ADD +